An employee holds pills at a pharmaceutical lab. (Photographer: Sara Hylton/Bloomberg)  

FDA Woes Hit Aurobindo Pharma As Unit 4 Gets Nine Observations

Aurobindo Pharma Ltd. received nine observations from the U.S. drug regulator for one of its Hyderabad units. That’s worrying for two reasons. One, it’s an injectables facility that’s required to m...

Bloomberg Quint

Add BloombergQuint App to Home screen.